FI940192L - 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina - Google Patents

2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina Download PDF

Info

Publication number
FI940192L
FI940192L FI940192A FI940192A FI940192L FI 940192 L FI940192 L FI 940192L FI 940192 A FI940192 A FI 940192A FI 940192 A FI940192 A FI 940192A FI 940192 L FI940192 L FI 940192L
Authority
FI
Finland
Prior art keywords
alkonol
hydroxypiperidino
derivatives
antianemic agents
antianemic
Prior art date
Application number
FI940192A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940192A7 (fi
FI940192A0 (fi
Inventor
Jr Willard Mckowan Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI940192A7 publication Critical patent/FI940192A7/fi
Publication of FI940192A0 publication Critical patent/FI940192A0/fi
Publication of FI940192L publication Critical patent/FI940192L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI940192A 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina FI940192L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17
PCT/US1992/004973 WO1993002052A1 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Publications (3)

Publication Number Publication Date
FI940192A7 FI940192A7 (fi) 1994-01-14
FI940192A0 FI940192A0 (fi) 1994-01-14
FI940192L true FI940192L (fi) 1994-01-14

Family

ID=24940103

Family Applications (2)

Application Number Title Priority Date Filing Date
FI940192A FI940192L (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina
FI981956A FI981956A0 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisia aineina

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI981956A FI981956A0 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisia aineina

Country Status (22)

Country Link
EP (1) EP0594729A1 (Sortimente)
JP (1) JP2571904B2 (Sortimente)
KR (1) KR0165003B1 (Sortimente)
CN (1) CN1043759C (Sortimente)
AU (1) AU655840B2 (Sortimente)
BR (1) BR9206272A (Sortimente)
CA (1) CA2113568A1 (Sortimente)
CZ (1) CZ284133B6 (Sortimente)
EG (1) EG20048A (Sortimente)
FI (2) FI940192L (Sortimente)
HU (1) HUT70528A (Sortimente)
IE (1) IE922311A1 (Sortimente)
IL (1) IL102473A (Sortimente)
MX (1) MX9204190A (Sortimente)
NO (1) NO180445C (Sortimente)
NZ (1) NZ243580A (Sortimente)
PL (1) PL169884B1 (Sortimente)
PT (1) PT100689B (Sortimente)
RU (1) RU2065859C1 (Sortimente)
TW (1) TW201732B (Sortimente)
WO (1) WO1993002052A1 (Sortimente)
ZA (1) ZA925306B (Sortimente)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
EP0666854B1 (en) * 1992-10-30 1997-03-26 Pfizer Inc. Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US6978166B2 (en) 1994-10-07 2005-12-20 Saint Louis University System for use in displaying images of a body part
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
CA2369695A1 (en) * 1999-04-09 2000-10-19 Manabu Itoh Agent for treating neuropathic pain
TWI254043B (en) * 1999-06-08 2006-05-01 Hoffmann La Roche Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
AU1153601A (en) 1999-10-29 2001-05-08 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole NMDA NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US7053089B2 (en) 2001-02-23 2006-05-30 Merck & Co., Inc. N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
CA2443108A1 (en) 2001-04-03 2002-10-17 Merck & Co. Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
AU2003302416A1 (en) 2002-11-25 2004-06-18 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
CA2541162A1 (en) * 2003-10-08 2005-04-21 Pfizer Inc. Fused lactam compounds
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途
EP4168116A4 (en) * 2020-06-23 2024-07-10 Biohaven Therapeutics Ltd. Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
CA2080475C (en) * 1990-05-10 2001-04-17 Bertrand Leo Chenard Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
NO940144L (no) 1994-01-14
WO1993002052A1 (en) 1993-02-04
PT100689A (pt) 1993-10-29
NO180445B (no) 1997-01-13
FI940192A7 (fi) 1994-01-14
JP2571904B2 (ja) 1997-01-16
CN1043759C (zh) 1999-06-23
IL102473A0 (en) 1993-01-14
AU2322592A (en) 1993-02-23
IE922311A1 (en) 1993-01-27
CZ400892A3 (en) 1994-03-16
CZ284133B6 (cs) 1998-08-12
CN1068566A (zh) 1993-02-03
FI940192A0 (fi) 1994-01-14
RU2065859C1 (ru) 1996-08-27
CA2113568A1 (en) 1993-02-04
FI981956A7 (fi) 1998-09-11
BR9206272A (pt) 1995-04-11
FI981956L (fi) 1998-09-11
NO180445C (no) 1997-04-23
PL169884B1 (pl) 1996-09-30
AU655840B2 (en) 1995-01-12
KR0165003B1 (en) 1999-01-15
HUT70528A (en) 1995-10-30
FI981956A0 (fi) 1998-09-11
IL102473A (en) 1997-07-13
NO940144D0 (no) 1994-01-14
MX9204190A (es) 1993-01-01
NZ243580A (en) 1994-10-26
HU9400136D0 (en) 1994-05-30
JPH06504293A (ja) 1994-05-19
PT100689B (pt) 1999-06-30
TW201732B (Sortimente) 1993-03-11
ZA925306B (en) 1994-01-17
EG20048A (en) 1997-03-27
EP0594729A1 (en) 1994-05-04

Similar Documents

Publication Publication Date Title
FI981956L (fi) 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisia aineina
NO934009D0 (no) Farmasoeytiske formuleringer
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A7 (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
FI925526A0 (fi) Kontrastmedel foer ultraljudsavbildning
FI923379L (fi) Terapeutiska amider
NO923127L (no) Farmasoeytisk kombinasjonsformulering
FI934194A7 (fi) Varjoaineita
NO940210D0 (no) Lukke for medikamentbroenn
MX9200622A (es) Composicion farmaceutica
NO934381D0 (no) Terapeutiske sammensetninger for osteoinduksjon
FI935452A7 (fi) Hydroksiamidiinijohdannaiset
FI921785A7 (fi) Farmaceutisk foerening
FI921786A7 (fi) Farmaceutisk foerening
FI931015A0 (fi) 2-(2-substituerade pyrrolidinyltio)karbapenemderivat
FI922425A7 (fi) Uudet 14-kruunu-4-eetterijohdannaiset
FI920701L (fi) Anordning foer terapeutisk tryckbehandling
FI941681A7 (fi) Tioformamidijohdannaiset
ITMI911049A0 (it) Composizione oftalmica
NO941294L (no) Tioformamid-derivat
SE9200780D0 (sv) Composition for therapeutic use
SE9101348D0 (sv) Pharmaceutical composition
SE9103213D0 (sv) Farmaceutisk komposition
ATE169214T1 (de) Psychoaktive propargylaminderivate